Growth factor signaling may affect the catalytic activity of PKM2, inducing its nuclear translocation, as we previously demonstrated in treating a human lung adenocarcinoma cell line with insulin-like growth factor 1 (IGF-1) [20]. The gene discussed is IGF1; the disease is lung adenocarcinoma.